These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16038786)

  • 21. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
    Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
    Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
    Tenorio EP; Saavedra R
    Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells.
    Herndler-Brandstetter D; Landgraf K; Jenewein B; Tzankov A; Brunauer R; Brunner S; Parson W; Kloss F; Gassner R; Lepperdinger G; Grubeck-Loebenstein B
    J Immunol; 2011 Jun; 186(12):6965-71. PubMed ID: 21562158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function.
    Jarvis LB; Matyszak MK; Duggleby RC; Goodall JC; Hall FC; Gaston JS
    Eur J Immunol; 2005 Oct; 35(10):2896-908. PubMed ID: 16180249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells.
    Wang D; Chen K; Du WT; Han ZB; Ren H; Chi Y; Yang SG; Bayard F; Zhu D; Han ZC
    Exp Cell Res; 2010 Sep; 316(15):2414-23. PubMed ID: 20420825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.
    Nasef A; Zhang YZ; Mazurier C; Bouchet S; Bensidhoum M; Francois S; Gorin NC; Lopez M; Thierry D; Fouillard L; Chapel A
    Int J Lab Hematol; 2009 Feb; 31(1):9-19. PubMed ID: 19143868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
    Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
    J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation.
    Aldinucci A; Rizzetto L; Pieri L; Nosi D; Romagnoli P; Biagioli T; Mazzanti B; Saccardi R; Beltrame L; Massacesi L; Cavalieri D; Ballerini C
    J Immunol; 2010 Nov; 185(9):5102-10. PubMed ID: 20889545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model.
    Li H; Guo ZK; Li XS; Hou CM; Tang PH; Mao N
    Cell Transplant; 2007; 16(1):85-95. PubMed ID: 17436858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
    Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
    Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
    Augello A; Tasso R; Negrini SM; Amateis A; Indiveri F; Cancedda R; Pennesi G
    Eur J Immunol; 2005 May; 35(5):1482-90. PubMed ID: 15827960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes of activation in T-lymphocyte subpopulations in peripheral blood during pregnancy].
    Ivanova-Todorova EI; Aĭvazova N; Mekhandzhiev TsR; Nalbanski A; Chernev T; Kiurkchiev DS
    Akush Ginekol (Sofiia); 2007; 46(2):3-8. PubMed ID: 17469443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
    Mishra PK
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.
    Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
    Exp Cell Res; 2005 Apr; 305(1):33-41. PubMed ID: 15777785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.